adenosine has been researched along with Peripheral Arterial Disease in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 20 (95.24) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cooney, KA; García, AJ; Han, WM; Hansen, LM; Levit, RD; Sayegh, MN; Strobel, F; Wang, L | 1 |
| Ahn, J-H; Gurbel, PA; Jeong, Y-H | 1 |
| Fowkes, FG; Hiatt, WR; Patel, MR | 1 |
| Uzoigwe, FA | 1 |
| Baumgartner, I; Berger, JS; Björck, M; Blomster, JI; Fowkes, FGR; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Norgren, L; Patel, MR; Rockhold, FW; Wojdyla, DM | 1 |
| Baracioli, LM; Giugliano, RP; Nicolau, JC | 1 |
| Erlinge, D; Larsson, J; Ohman, J; Salmi, H; Torngren, K | 1 |
| Nilsen, DW | 1 |
| den Dekker, MA; Jaspers, MM; Oudkerk, M; Tielliu, IF; Tio, RA; van den Dungen, JJ; Vliegenthart, R | 1 |
| Becker, RC; Emanuelsson, H; Hiatt, WR; Horrow, J; Husted, S; James, SK; Mahaffey, KW; Patel, MR; Steg, PG; Storey, RF; Wallentin, L; Wojdyla, DM | 1 |
| Cafaro, G; de Gaetano, G; Di Minno, A; Di Minno, G; Lupoli, R; Petitto, M; Spadarella, G; Tremoli, E | 1 |
| Chong, AY; So, DY | 1 |
| Abola, MTB; Aylward, P; Bhatt, DL; Bonaca, MP; Braunwald, E; Cohen, M; Corbalán, R; Dalby, A; Dellborg, M; Goodrich, E; Held, P; Jensen, EC; Kuder, J; López-Sendón, J; Nicolau, JC; Parkhomenko, A; Sabatine, MS; Špinar, J; Steg, PG; Storey, RF | 1 |
| Bonello, L; Dignat-Georges, F; Fromonot, J; Guieu, R; Kipson, N; Mottola, G; Paganelli, F; Rossi, P; Ruf, J | 1 |
| Baumgartner, I; Berger, JS; Blomster, J; Fowkes, FG; Heizer, G; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Millegård, M; Norgren, L; Patel, MR; Reist, C | 2 |
| Drebes, A; Klonaris, C; Liakakos, T; Matheiken, S; Patelis, N | 1 |
| Baumgartner, I; Berger, JS; Blomster, J; Conte, MS; Fowkes, FG; Heizer, G; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Millegård, M; Norgren, L; Patel, MR; Reist, C; White, CJ | 1 |
| Badhey, N; Banerjee, S; Brilakis, ES; Lichtenwalter, C; Varghese, C | 1 |
| Ashraf, J; Giugliano, GR; Lotfi, AS; Sivalingam, SK; Visintainer, P | 1 |
| Serebruany, VL | 1 |
4 review(s) available for adenosine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease.
Topics: Acute Coronary Syndrome; Adenosine; Government Regulation; Half-Life; Hemorrhage; Humans; Myocardial Infarction; Peripheral Arterial Disease; Purinergic P2Y Receptor Antagonists; Ticagrelor; Treatment Outcome | 2018 |
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
Topics: Adenosine; Aspirin; Asymptomatic Diseases; Cilostazol; Clopidogrel; Fibrinolytic Agents; Humans; Intermittent Claudication; Ischemia; Lower Extremity; Meta-Analysis as Topic; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Primary Prevention; Review Literature as Topic; Secondary Prevention; Stroke; Tetrazoles; Thrombosis; Ticagrelor; Ticlopidine | 2014 |
Ticagrelor for the treatment of peripheral arterial disease.
Topics: Adenosine; Animals; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2014 |
Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents.
Topics: Adenosine; Adenosine Monophosphate; Imines; Lactones; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Quinazolinones; Sulfonamides; Ticagrelor | 2016 |
7 trial(s) available for adenosine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
Topics: Adenosine; Aged; Clopidogrel; Female; Hospitalization; Humans; Hypertension; Incidence; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome; Vascular Surgical Procedures | 2018 |
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Double-Blind Method; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Stroke; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2015 |
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Topics: Adenosine; Aged; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemia; Lower Extremity; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Stroke; Ticagrelor; Vascular Grafting | 2016 |
Ticagrelor Improves Peripheral Arterial Function in Acute Coronary Syndrome Patients: Relationship With Adenosine Plasma Level.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Arteries; Aspirin; Biomarkers; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Extremities; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Severity of Illness Index; Survival Rate; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Topics: Adenosine; Aged; Ankle Brachial Index; Clopidogrel; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Topics: Adenosine; Aged; Clopidogrel; Female; Humans; Lower Extremity; Male; Peripheral Arterial Disease; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome | 2017 |
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Topics: Adenosine; Aged; Cardiovascular Diseases; Clopidogrel; Double-Blind Method; Female; Hemorrhage; Humans; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Leg; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
10 other study(ies) available for adenosine and Peripheral Arterial Disease
| Article | Year |
|---|---|
A Hydrogel Strategy to Augment Tissue Adenosine to Improve Hindlimb Perfusion.
Topics: 5'-Nucleotidase; Adenosine; Animals; Cells, Cultured; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Female; Hindlimb; Humans; Hydrogels; Ischemia; Male; Maleimides; Mice, Inbred C57BL; Neutrophil Activation; Peripheral Arterial Disease; Polyethylene Glycols; Regional Blood Flow; Up-Regulation | 2021 |
Ticagrelor versus Clopidogrel in Peripheral Artery Disease.
Topics: Adenosine; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Ticlopidine | 2017 |
Ticagrelor versus Clopidogrel in Peripheral Artery Disease.
Topics: Adenosine; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Ticlopidine | 2017 |
Ticagrelor versus Clopidogrel in Peripheral Artery Disease.
Topics: Adenosine; Humans; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Ticlopidine | 2017 |
Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Blood Pressure; Case-Control Studies; Clopidogrel; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Peripheral Arterial Disease; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome | 2013 |
Potential benefits of ticagrelor beyond platelet inhibition.
Topics: Acute Coronary Syndrome; Adenosine; Female; Humans; Male; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists | 2013 |
Prevalence of severe subclinical coronary artery disease on cardiac CT and MRI in patients with extra-cardiac arterial disease.
Topics: Adenosine; Aged; Asymptomatic Diseases; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Peripheral Arterial Disease; Prevalence; Prospective Studies; Referral and Consultation; Tomography, X-Ray Computed; Vascular Calcification; Vasodilator Agents | 2013 |
Relationship of walking impairment and ankle-brachial index assessments with peripheral arterial translesional pressure gradients.
Topics: Adenosine; Ankle Brachial Index; Blood Pressure; Female; Gait Ataxia; Health Status Indicators; Humans; Male; Middle Aged; Nitroglycerin; Peripheral Arterial Disease; Rest; Risk Factors; Statistics as Topic; Surveys and Questionnaires; Vasodilator Agents; Walking | 2011 |
Use of fraction flow reserve to predict changes over time in management of superficial femoral artery.
Topics: Adenosine; Aged; Aged, 80 and over; Ankle; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Female; Femoral Artery; Humans; Male; Massachusetts; Middle Aged; Peripheral Arterial Disease; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2012 |
Peripheral vascular outcomes in the PLATO trial: update from the FDA ticagrelor complete response review.
Topics: Acute Coronary Syndrome; Adenosine; Clinical Trials, Phase III as Topic; Humans; Multicenter Studies as Topic; Peripheral Arterial Disease; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Stroke; Ticagrelor | 2012 |